Alkem Laboratories Incorporates Dubai Pharma Trading Subsidiary

Alkem Laboratories incorporated a wholly owned subsidiary, Alkem Pharma Trading FZCO, in Dubai, UAE on March 27, 2026.
The subsidiary was established with AED 3.67 million capital to export company products to African, South East Asian, and non-UAE markets.
Disclosure is made pursuant to SEBI LODR Regulation 30 following receipt of the Certificate of Formation on April 13, 2026.
The acquisition constitutes a related party transaction as it is a wholly owned subsidiary of Alkem Laboratories.